Wetang’ula Says MP Ferdinand Wanyonyi Recovering Well in India

National Assembly Speaker Moses Wetang’ula has said Kwanza MP Ferdinand Wanyonyi is in stable condition and responding well to specialised treatment at a hospital in Kerala, India.

Wetang’ula confirmed that Wanyonyi is undergoing a rehabilitation programme at KIMS Health Care Management Limited, where he is being treated by specialists in physical medicine. The MP has been away from parliamentary duties for much of the past year due to illness.

After visiting the facility, the Speaker said he was encouraged by the lawmaker’s progress and assured by the medical team that his recovery was on course. He thanked the hospital staff for their professionalism and commitment to Wanyonyi’s care.

Wetang’ula also used the visit to reflect on the growing number of Kenyans seeking advanced medical treatment in India. He cited the country’s medical technology, specialist expertise, and relative affordability as key reasons for this trend.

He said insights gained from the visit would inform discussions in Parliament on strengthening Kenya’s healthcare system.

Proposed areas of focus include improved referral systems, specialist training, and partnerships in medical research between Kenyan and Indian institutions. The Speaker has previously addressed Wanyonyi’s condition.

In December last year, he dismissed false reports circulating online that the MP had died, describing them as malicious. He later confirmed that Wanyonyi had initially been treated in Nairobi before being referred abroad.

Wanyonyi has been accompanied throughout his treatment by his wife and daughter, who have provided ongoing support during his recovery. The MP is serving his third consecutive term representing Kwanza Constituency, having first been elected in 2013.

Before entering politics, he held senior positions in both public and private sectors, including leadership roles at the Lake Basin Development Authority and the Tana & Athi River Development Authority, as well as commercial roles at Kodak Ltd and Bayer (EA) Ltd.